查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1966221

2026-2034年全球鼻腔给药技术市场规模、份额、趋势和成长分析报告

Global Nasal Drug Delivery Technology Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计鼻腔给药技术市场将从 2025 年的 880.9 亿美元成长到 2034 年的 1,656.7 亿美元，2026 年至 2034 年的复合年增长率为 7.27%。

由于对非侵入性、快速给药方式的需求不断增长，全球鼻腔给药技术市场正稳步发展。与注射药物相比，鼻腔给药系统吸收速度更快，从而提高了患者的依从性。呼吸系统和神经系统疾病的日益普遍也推动了对创新给药技术的需求。

关键成长要素包括製剂技术的进步、生技药品使用量的增加以及患者对自行给药装置的偏好日益增长。鼻喷剂和粉剂系统因其便利性和有效性而越来越受欢迎。透过鼻腔途径标靶递送药物至大脑的研究不断深入，进一步提升了市场的潜力。

展望未来，市场成长预计将得益于设备设计和药物配方的持续创新。个人化医疗方法和居家医疗服务的扩展有望创造新的机会。在新兴市场，随着医疗基础设施的改善，预计市场接受度将会提高。精准给药技术的发展可望塑造未来的市场模式。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球鼻腔给药技术市场：依产品类型划分

  • 市场分析、洞察与预测
  • 喷
  • 滴鼻剂和液体药物
  • 凝胶
  • 粉末

第五章：全球鼻腔给药技术市场：依血管类型划分

  • 市场分析、洞察与预测
  • 加压容器
  • 非加压容器

第六章：全球鼻腔给药技术市场：依应用划分

  • 市场分析、洞察与预测
  • 鼻塞
  • 鼻炎
  • 气喘
  • 疫苗接种
  • 其他的

第七章 全球鼻腔给药技术市场：依分销管道划分

  • 市场分析、洞察与预测
  • 医院药房
  • 零售药房
  • 电子商务

第八章：全球鼻腔给药技术市场：依最终用途划分

  • 市场分析、洞察与预测
  • 医院
  • 诊所
  • 居家医疗
  • 其他的

第九章：全球鼻腔给药技术市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 南非
    • 其他中东和非洲国家

第十章 竞争格局

  • 最新趋势
  • 公司分类
  • 供应链和分销通路合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十一章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Aegis Therapeutics
    • AptarGroup
    • Boehringer Ingelheim
    • Eli Lilly And Company
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline
    • Horizon Therapeutics
    • Johnson & Johnson
    • Merck
    • Nasal Technologies
    • Neuralstem
简介目录
Product Code: VMR11210590

The Nasal Drug Delivery Technology Market size is expected to reach USD 165.67 Billion in 2034 from USD 88.09 Billion (2025) growing at a CAGR of 7.27% during 2026-2034.

The Global Nasal Drug Delivery Technology Market has grown steadily due to increasing demand for non-invasive and rapid drug administration methods. Nasal delivery systems provide quick absorption and improved patient compliance compared to injectable alternatives. Rising prevalence of respiratory and neurological disorders has strengthened demand for innovative delivery technologies.

Major growth drivers include advancements in formulation technologies, increasing use of biologics, and growing preference for self-administration devices. Nasal sprays and powder-based systems are gaining popularity due to convenience and effectiveness. Expanding research into targeted brain delivery through the nasal route further enhances market potential.

Looking ahead, the market is expected to grow with continuous innovation in device design and drug formulations. Personalized medicine approaches and expansion of home healthcare services will create additional opportunities. Emerging markets are anticipated to witness rising adoption due to improving healthcare infrastructure. Technological progress in precision dosing will shape the future landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Sprays
  • Drops And Liquids
  • Gels
  • Powders

By Container Type

  • Pressurized Containers
  • Non-Pressurized Containers

By Application

  • Nasal Congestion
  • Rhinitis
  • Asthma
  • Vaccination
  • Other Applications

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

By End Use

  • Hospitals
  • Clinics
  • Homecare Settings
  • Other End Users

COMPANIES PROFILED

  • Aegis Therapeutics, AptarGroup, Boehringer Ingelheim, Eli Lilly and Company, F HoffmannLa Roche AG, GlaxoSmithKline, Horizon Therapeutics, Johnson Johnson, Merck, Nasal Technologies, Neuralstem

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Sprays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Drops And Liquids Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Gels Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Powders Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET: BY CONTAINER TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Container Type
  • 5.2. Pressurized Containers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Non-Pressurized Containers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Nasal Congestion Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Rhinitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Vaccination Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Distribution Channel
  • 7.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET: BY END USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End Use
  • 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product Type
    • 9.2.2 By Container Type
    • 9.2.3 By Application
    • 9.2.4 By Distribution Channel
    • 9.2.5 By End Use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product Type
    • 9.3.2 By Container Type
    • 9.3.3 By Application
    • 9.3.4 By Distribution Channel
    • 9.3.5 By End Use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product Type
    • 9.4.2 By Container Type
    • 9.4.3 By Application
    • 9.4.4 By Distribution Channel
    • 9.4.5 By End Use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product Type
    • 9.5.2 By Container Type
    • 9.5.3 By Application
    • 9.5.4 By Distribution Channel
    • 9.5.5 By End Use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product Type
    • 9.6.2 By Container Type
    • 9.6.3 By Application
    • 9.6.4 By Distribution Channel
    • 9.6.5 By End Use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL NASAL DRUG DELIVERY TECHNOLOGY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Aegis Therapeutics
    • 11.2.2 AptarGroup
    • 11.2.3 Boehringer Ingelheim
    • 11.2.4 Eli Lilly And Company
    • 11.2.5 F. Hoffmann-La Roche AG
    • 11.2.6 GlaxoSmithKline
    • 11.2.7 Horizon Therapeutics
    • 11.2.8 Johnson & Johnson
    • 11.2.9 Merck
    • 11.2.10 Nasal Technologies
    • 11.2.11 Neuralstem